Netherlands· NL-ad75abe055f2
Act-Hib, 10 microgram/0,5 ml poeder en oplosmiddel voor oplossing voor injectie
A haemophilus influenzae b, gereinigtes antigen konjugiert product containing haemophilus influenzae type b polysaccharide geconjugeerd aan tetanus toxoïd (prp-t), registered in Netherlands by Sanofi Winthrop Industrie. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Haemophilus influenzae b, gereinigtes antigen konjugiert is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AG01 (haemophilus influenzae b, gereinigtes antigen konjugiert), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Haemophilus influenzae b, gereinigtes antigen konjugiert · ATC J07AG01
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE GECONJUGEERD AAN TETANUS TOXOÏD (PRP-T)
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Netherlands (NL)
- ATC code
- J07AG01
- ATC class
- Haemophilus influenzae B, gereinigtes Antigen konjugiert
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id17508
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AG01
Haemophilus influenzae b, gereinigtes antigen konjugiert, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/038980f4-5371-4bc6-99fd-ba4034c86feb GET /v1/drugs/038980f4-5371-4bc6-99fd-ba4034c86feb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor injectie",
"route": "Subcutaan gebruik, Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17508_smpc.pdf",
"strength": null,
"atc_label": "Hemophilus Influenzae B, Purified Antigen Conjugated",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg17508",
"excipients": [
"NATRIUMCHLORIDE",
"SACCHAROSE",
"STIKSTOF (HEAD SPACE) (E 941)",
"TROMETAMOL",
"WATER VOOR INJECTIE"
],
"substances": [
"HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE GECONJUGEERD AAN TETANUS TOXOÏD (PRP-T)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h17508.pdf",
"authorised_at": "1993/12/02",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "17508",
"additional_monitoring": "N"
}See everything about haemophilus influenzae b, gereinigtes antigen konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.